Johnson & Johnson
http://www.jnj.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Johnson & Johnson
Inside US FDA’s Return To In-Person Meetings
In an interview, OND Deputy Director of Operations Kevin Bugin describes how FDA might be able to "accelerate" the transition back to in-person meetings if the initial phase with Type A and BPD Type 1 meetings goes well. But there is still no plan to return to in-person advisory committees.
All Eyes On Amjevita, Amgen’s Humira Biosimilar And Sole 2023 Product Launch
The company launched Amjevita on the same day it announced fourth quarter 2022 earnings and provided 2023 guidance, upping the high-profile nature of the first-to-market US Humira biosimilar.
Gilead Keeps Focus On HIV, Long-Acting Drugs And Growth Through Oncology
Even with top-seller Biktarvy and its preventive therapy, Descovy, protected beyond this decade from generics, Gilead is investing aggressively in long-acting HIV candidates and its oncology pipeline.
Pfizer’s COVID-19 Franchise Dominates Best-Seller List
Comirnaty was the industry’s top-selling product through the first three quarters of 2022, as in 2021, but Paxlovid proved a fast riser while Comirnaty and Moderna’s Spikevax saw declining sales. Pfizer's two COVID-19 products netted £46bn in total.
Company Information
- Industry
- In Vitro Diagnostics
- Medical Devices
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Abiomed, Inc.
- Acclarent Inc.
- Actelion Pharmaceuticals Ltd.
- AdvanceCOR GmbH
- ALZA Corporation
- Alios BioPharma, Inc.
- Animas Corporation
- Aragon Pharmaceuticals, Inc.
- Auris Health, Inc.
- Auris Surgical Robotics
- BeneVir Biopharm, Inc.
- BioMedical Enterprises, Inc.
- Biosense Webster, Inc.
- Calibra Medical, Inc.
- Centyrex Internal Venture
- Cilag AG
- Cerenovus
- Codman & Shurtleff, Inc
- Coherex Medical, Inc.
- Conor Medsystems, Inc.
- Cordis Webster, Inc.
- CorImmun GmbH
- Cougar Biotechnology, Inc.
- Covagen AG
- Crucell N.V.
- DePuy Mitek, Inc.
- DePuy Orthopaedics, Inc.
- DePuy Synthes, Inc.
- Ensure Medical
- Ethicon, Inc.
- FemRx Inc.
- Flexible Stenting Solutions, Inc.
- Gynecare, Inc.
- Hansen Medical, Inc.
- Innovative Surgical Solutions, LLC
- Interventional Spine, Inc.
- Janssen Biotech, Inc. (formerly Centocor Ortho Biotech Inc.)
- Janssen Diagnostics
- Janssen Pharmaceuticals
- Janssen Vaccines & Prevention B.V.
- JointPoint, Inc.
- LifeScan, Inc.
- Medical Enterprises Distribution, LLC
- Medos International SARL
- Megadyne Medical Products, Inc.
- Mentor Corporation
- Micrus Endovascular Corporation
- Molsaic Internal Venture
- Momenta Pharmaceuticals, Inc.
- NeoStrata Company, Inc.
- Neuravi Limited
- NeuWave Medical, Inc.
- Novira Therapeutics
- Omrix Biopharmaceuticals, Inc.
- Ortho Biotech Products, L.P.
- Ortho-McNeil, Inc.
- Orthotaxy
- Peninsula Pharmaceuticals, Inc.
- Pulsar Vascular Inc
- RespiVert Ltd.
- Scios, Inc.
- Selected Nerve Stimulation Internal Ventures
- Sentio, LLC
- Sequus Pharmaceuticals
- Stem Cell Internal Venture
- Synthes, Inc.
- Tibotec
- Torax Medical, Inc.
- Triage Medical, Inc.
- Verb Surgical Inc.
- Veridex
- Vigor Sub, Inc.
- Vistakon
- XO1 Limited
- TARIS Biomedical LLC
- Verb Surgical, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice